top of page

It's not just about period apps

The Femtech Revolution

Imagine a world where women’s health isn’t just a niche category but a dynamic and rapidly evolving sector at the forefront of medical innovation. That world is no longer a distant dream. From groundbreaking investments to a shift in focus toward comprehensive women’s health, 2024 is shaping up to be a landmark year. Here’s a deep dive into the trends and predictions shaping the future of FemTech.

The FemTech sector is experiencing explosive growth and transformation:

  • Remarkable Investment Surge: Venture capital investment in FemTech has soared by 314% since 2018.

  • Beyond Reproductive Health: Investments in startups focused on non-reproductive health reached $435 million in Q3 2023, challenging the misconception that FemTech is limited to fertility and pregnancy.

  • Biopharma on the Rise: With an average of $182 million invested per quarter, biopharma has overtaken healthtech as the leading FemTech subsector in 2023.

  • Women-Led Innovation: A significant 76% of FemTech companies have a female founder, a rate three times higher than in the broader innovation ecosystem.

What to Expect in 2024

Growth in non-reproductive health

Investment is increasingly directed toward areas like menopause, pelvic floor health, incontinence, and endometriosis. Wearable technology for managing menopause symptoms is expected to grow significantly, improving the quality of life for many women.

Addressing unmet needs with life sciences

FemTech is evolving beyond healthtech, with a growing focus on diagnostics, devices, and therapeutics. Innovations like non-invasive prenatal genetic testing and AI-guided reproductive planning are set to revolutionize the field.

The rise of dedicated fem tech funds

The vast market potential in FemTech is attracting more investment firms. These funds are supporting startups in advanced maternal care, precision oncology, and other areas, transforming the landscape.

VC investments shifts to later stages

While early-stage investments remain significant, there's a growing trend towards later-stage funding. This shift supports companies through their growth phases, essential for developing sophisticated solutions requiring substantial R&D and clinical validation.

The Road Ahead

The future of FemTech is incredibly bright, fueled by a surge in investment and a broader focus on addressing long-overlooked issues. The era of limited attention to women’s health is coming to an end. With dedicated funds, innovative solutions, and a growing number of women-led companies, the sector is poised for groundbreaking advancements.

We are moving beyond the era of period apps and embracing a comprehensive approach to women’s health. From periods to menopause and everything in between, the opportunities for innovation are limitless. The journey has just begun, and the potential for transforming women’s health is immense.

Join us tomorrow in our health & wellness CVC panel discussion! RSVP


bottom of page